Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Intense exercise is a major challenge to the management of type 1 diabetes (T1D). Closed-loop control (CLC) systems (artificial pancreas) improve glycemic control during limited intensity and short duration of physical activity (PA). However, CLC has not been tested during extended vigorous outdoor exercise common among adolescents. RESEARCH DESIGN AND METHODS: Skiing presents unique metabolic challenges: intense prolonged PA, cold, altitude, and stress/fear/excitement. In a randomized controlled trial, 32 adolescents with T1D (ages 10–16 years) participated in a 5-day ski camp (∼5 h skiing/day) at two sites: Wintergreen, VA, and Breckenridge, CO. Participants were randomized to the University of Virginia CLC system or remotely monitored sensor-augmented pump (RM-SAP). The CLC and RM-SAP groups were coarsely paired by age and hemoglobin A1c (HbA1c). All subjects were remotely monitored 24 h per day by the study physicians and clinical team. RESULTS: Compared with physician-monitored open loop, percent time in range (70–180 mg/dL) improved using CLC: 71.3 vs. 64.7% (+6.6% [95% CI 1–12]; P = 0.005), with maximum effect late at night. Hypoglycemia exposure and carbohydrate treatments were improved overall (P = 0.001 and P = 0.007) and during the daytime with strong ski level effects (P = 0.0001 and P = 0.006); ski/snowboard proficiency was balanced between groups but with a very strong site effect: naive in Virginia and experienced in Colorado. There was no adverse event associated with CLC; the participants’ feedback was overwhelmingly positive. CONCLUSIONS: CLC in adolescents with T1D improved glycemic control and reduced exposure to hypoglycemia during prolonged intensive winter sport activities, despite the added challenges of cold and altitude.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and (3) the first”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [128]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Automated insulin delivery systems can potentially modify insulin dosing in response to activity monitors to reduce the risk (or severity) of exercise-induced hypoglycemia in people living with type 1 diabetes [7-10].”
From Accuracy of Wrist-Worn Activity Monitors During Common Daily Physical Activities and Types of Structured Exercise: Evaluation Study (2018) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
Self-citationSafety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Weinzimer, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., & Tamborlane, W. V. (2008) · Diabetes Care · doi:10.2337/dc07-1967 · Cited by 567
Hovorka, R., Allen, J. M., Elleri, D., Chassin, L. J., Harris, J., Xing, D., Kollman, C., Hovorka, T., Larsen, A. M. F., Nodale, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61998-x · Cited by 450 · cited 2×
“control while decreasing the rates of hyperglycemia and hypoglycemia in inpatient trials (5,10,11), at diabetes camps”
BackgroundMethodHome Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
Phillip, M., Battelino, T., Atlas, E., Kordonouri, O., Bratina, N., Miller, S., Biester, T., Avbelj Stefanija, M., Muller, I., Nimri, R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206881 · Cited by 435 · cited 1×
“There have also been several older studies investigating the role of overnight glucose control with AP in a camp setting (13,26) that confirmed the trend of re-”
BackgroundClosed-Loop Artificial Pancreas Systems: Engineering the Algorithms
Doyle, F. J., Huyett, L. M., Lee, J. B., Zisser, H. C., & Dassau, E. (2014) · Diabetes Care · doi:10.2337/dc13-2108 · Cited by 394 · cited 1×
“CLC systems involve the pairing of a continuous subcutaneous insulin infusion pump and a continuous glucose monitor (CGM) with a CLC algorithm that automatically adjusts insulin infusion in real time (4).”
BackgroundComing of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223 · cited 2×
“Reviews and collections of papers reflecting the progress of the AP field are published regularly (2,3).”
BackgroundOutcome measures for artificial pancreas clinical trials: a consensus report
Maahs, D. M., Buckingham, B. A., Castle, J. R., Cinar, A., Damiano, E. R., Dassau, E., DeVries, J. H., Doyle, F. J., Griffen, S. C., Haidar, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2716 · Cited by 211 · cited 1×
“Primary outcome was the percent time spent between 70 and 180 mg/dL (22), with secondary outcomes focusing on the quality of glycemic control, including percent time spent between 70 and 140 mg/dL, average CGM, and total insulin used.”
BackgroundSelf-citationRussell, S. J., Hillard, M. A., Balliro, C., Magyar, K. L., Selagamsetty, R., Sinha, M., Grennan, K., Mondesir, D., Ekhlaspour, L., Zheng, H., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00489-1 · Cited by 179
Kovatchev, B. P., Renard, E., Cobelli, C., Zisser, H. C., Keith-Hynes, P., Anderson, S. M., Brown, S. A., Chernavvsky, D. R., Breton, M. D., Mize, L. B., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2076 · Cited by 178 · cited 1×
“inpatient investigations using algorithmdriven manual control (5) to long-term clinical trials in free-living conditionsusing portable wireless automated CLC systems (6).”
MethodSelf-citationLy, T. T., Breton, M. D., Keith-Hynes, P., DeSalvo, D. J., Clinton, P. K., Benassi, K., Mize, B., Cherñavvsky, D. R., Place, J., Wilson, D. M., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0147 · Cited by 135
Self-citationTaleb, N., Emami, A., Suppère, C., Messier, V., Legault, L., Ladouceur, M., Chiasson, J., Haidar, A., & RABASA-LHORET, R. P. R. (2016) · Diabetologia · doi:10.1007/s00125-016-4107-0 · Cited by 133
Breton, M. D., Brown, S. A., Karvetski, C. H., Kollar, L., Topchyan, K. A., Anderson, S. M., & Kovatchev, B. P. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0333 · Cited by 128
Self-citationSherr, J. L., Cengiz, E., Palerm, C. C., Clark, B., Kurtz, N., Roy, A., Carria, L., Cantwell, M., Tamborlane, W. V., & Weinzimer, S. A. (2013) · Diabetes Care · doi:10.2337/dc13-0010 · Cited by 125
Multinational Home Use of Closed-Loop Control Is Safe and Effective
Anderson, S. M., Raghinaru, D., Pinsker, J. E., Boscari, F., Renard, E., Buckingham, B. A., Nimri, R., Doyle, F. J., Brown, S. A., Keith-Hynes, P., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2468 · Cited by 120
Self-citationJacobs, P. G., El Youssef, J., Reddy, R., Resalat, N., Branigan, D., Condon, J., Preiser, N., Ramsey, K., Jones, M., Edwards, C., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12707 · Cited by 116
The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes
Kovatchev, B., Tamborlane, W. V., Cefalu, W. T., & Cobelli, C. (2016) · Diabetes Care · doi:10.2337/dc16-0824 · Cited by 95 · cited 2×
“Reviews and collections of papers reflecting the progress of the AP field are published regularly (2,3).”
BackgroundSelf-citationDel Favero, S., Boscari, F., Messori, M., Rabbone, I., Bonfanti, R., Sabbion, A., Iafusco, D., Schiaffini, R., Visentin, R., Calore, R., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2815 · Cited by 94 · cited 1×
“(24) published results of a 3-day summer camp study in children 5–9 years old comparing singlehormone AP against SAP and found a re-”
BackgroundDiAs User Interface: A Patient-Centric Interface for Mobile Artificial Pancreas Systems
Keith-Hynes, P., Guerlain, S. A. E., Mize, B., Karvetski, C., Khan, M., McElwee-Malloy, M., & Kovatchev, B. P. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700602 · Cited by 89 · cited 1×
“hub to run the CLC algorithm and included an AP user interface, a cloud-based remote monitoring, and an automated alert system (8,9).”
MethodSelf-citationThe Diabetes Assistant: A Smartphone-Based System for Real-Time Control of Blood Glucose
Keith-Hynes, P., Mize, B., Robert, A., & Place, J. (2014) · Electronics · doi:10.3390/electronics3040609 · Cited by 77 · cited 13×
“All subjects used a DiAs system (UVA) (9), linked to their CGM system, which reported data back to the UVA remote monitoring system (DiAs”
MethodInfluentialDeBoer, M. D., Cherñavvsky, D. R., Topchyan, K. A., Kovatchev, B. P., Francis, G. L., & Breton, M. D. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12454 · Cited by 69
Self-citationPlace, J., Robert, A., Brahim, N. B., Keith-Hynes, P., Farret, A., Pelletier, M.-J., Buckingham, B. A., Breton, M. D., Kovatchev, B. P., & Renard, É. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700603 · Cited by 63 · cited 1×
“24 h per day, using the DWM system (21) (Fig.”
MethodSelf-citationManaging insulin therapy during exercise in type 1 diabetes mellitus.
Toni, S., Reali, M. F., Barni, F., Lenzi, L., & Festini, F. (2006) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 62
Automated Overnight Closed-Loop Glucose Control in Young Children with Type 1 Diabetes
Elleri, D., Allen, J. M., Nodale, M., Wilinska, M. E., Mangat, J. S., Larsen, A. M. F., Acerini, C. L., Dunger, D. B., & Hovorka, R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0176 · Cited by 59 · cited 1×
“control while decreasing the rates of hyperglycemia and hypoglycemia in inpatient trials (5,10,11), at diabetes camps”
BackgroundPsychosocial impact of the bionic pancreas during summer camp
Weissberg-Benchell, J., Hessler, D., Polonsky, W. H., & Fisher, L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816640289 · Cited by 47 · cited 1×
“The use of CLC systems hasdecreasedhypoglycemia fearandburden among children attending summer camp (23).”
BackgroundExercise in Youth with Type 1 Diabetes
Roberts, A. J. C., & Taplin, C. E. (2015) · Current Pediatric Reviews · doi:10.2174/1573396311666150702105340 · Cited by 43
Ly, T. T., Buckingham, B. A., DeSalvo, D. J., Shanmugham, S., Satin-Smith, M., DeBoer, M. D., Oliveri, M. C., Schertz, E., Breton, M. D., & Cherñavvsky, D. R. (2016) · Diabetes Care · doi:10.2337/dc16-0817 · Cited by 41 · cited 1×
“Using the DiAs system developed at the University of Virginia (UVA), we have conducted clinical trials in summer and winter camp settings where PA was typically much greater than during daily life for adolescents and young adults (13,20).”
MethodSelf-citationPatel, N. S., Name, M. A. V., Cengiz, E., CARRIA, L. R., TICHY, E. M., Weyman, K., WEINZIMER, S. A., Tamborlane, W. V., & Sherr, J. L. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0311 · Cited by 38
Cited by
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Breton, M. D., Kanapka, L. G., Beck, R. W., Ekhlaspour, L., Forlenza, G. P., Cengiz, E., Schoelwer, M., Ruedy, K. J., Jost, E., Carria, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004736 · Cited by 455
Self-citationBekiari, E., Kitsios, K., Thabit, H., Tauschmann, M., Athanasiadou, E., Karagiannis, T., Haidich, A.-B., Hovorka, R., & Tsapas, A. (2018) · BMJ · doi:10.1136/bmj.k1310 · Cited by 437
Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., Ekhlaspour, L., Church, M. M., Weinzimer, S. A., Jost, E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0771 · Cited by 246
Self-citationBenhamou, P.-Y., Franc, S., Reznik, Y., Thivolet, C., Schaepelynck, P., Renard, E., Guerci, B., Chaillous, L., Lukas-Croisier, C., Jeandidier, N., et al. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30003-2 · Cited by 217
Moser, O., Riddell, M. C., Eckstein, M. L., Adolfsson, P., Rabasa-Lhoret, R., van den Boom, L., Gillard, P., Nørgaard, K., Oliver, N. S., Zaharieva, D. P., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05263-9 · Cited by 214
Metadata
- Authors
- Breton, M. D., Cherñavvsky, D. R., Forlenza, G. P., DeBoer, M. D., Robic, J., Wadwa, R. P., Messer, L. H., Kovatchev, B. P., & Maahs, D. M.
- Affiliations
- University of Virginia (US)
- University of Colorado Denver (US)
- Corresponding author
- Breton, Marc D.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-30
- Volume
- 40
- Issue
- 12
- Pages
- 1644-1650
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC5711335
- OpenAlex
- W2752733073
- Cited by
- 179
- References
- 31
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 11 · 2023: 18 · 2022: 10 · 2021: 17 · 2020: 36 · 2019: 31 · 2018: 28 · 2017: 3
- FWCI
- 21.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH-DP3-DK106826)
- University of Colorado Foundation
- Children’s Diabetes Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, feedback control, artificial pancreas, adolescents, prolonged exercise, skiing, glycemic control, hypoglycemia, time in range, sensor-augmented pump, cold exposure, altitude, winter sports
- MeSH terms
- Adolescent, Blood Glucose, Child, Cold Temperature, Colorado, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Humans, Hypoglycemia, Seasons, Skiing, Virginia, Blood Glucose Self-Monitoring, Exercise, Body Mass Index, Treatment Outcome, Pancreas, Artificial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.